ALFALEX

This brand name is authorized in Nigeria.

Active ingredients

The drug ALFALEX contains one active pharmaceutical ingredient (API):

1	Celecoxib UNII JCX84Q7J1L - CELECOXIB
	Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.
	Read more about Celecoxib

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100492	Capsule	Alfalex Capsules (duplicate) CAP 200 mg 1 x 10's (in PVC-Alu blisters)	Blue cap with white body capsules which contain white to off white powder 1 NF-PP-84804 ALFALEX CAPSULES CELECOXIB CELECOXIB:200.00MG,LACTOSE MONOHYDRATE:51.70MG,CROSCARMELLOSE SODIUM:8.00MG,POVIDON K-30:6.30MG,SODIUM LAURYL SULFATE:2.00MG,MAGNESIUM STEARATE:2.00MG,HARD GELATIN CAPSULE:80.85MG. A4-5967 Drugs VARIOUS Nigerian Products 110 POM 1 4/14/2023 AFRAB-CHEM LIMITED, , ABIMBOLA STREET, ISOLO INDUSTRIAL ESTATE, ISOLO LAGOS 12700057 oyeyemiat2005@yahoo.com AFRAB CHEM LIMITED, 22, ABIMBOLA STREET, ISOLO INDUSTRIAL ESTATE, ISOLO-LAGOS, Nigeria	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AH01	Celecoxib	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100492